Acarix AB (publ) (STO:ACARIX)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.3000
+0.0130 (4.53%)
Sep 5, 2025, 5:29 PM CET
4.53%
Market Cap337.00M
Revenue (ttm)5.56M
Net Income (ttm)-61.57M
Shares Out1.12B
EPS (ttm)-0.06
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,042,762
Average Volume2,011,243
Open0.3000
Previous Close0.2870
Day's Range0.2865 - 0.3025
52-Week Range0.1688 - 0.4710
Beta1.06
RSI41.21
Earnings DateAug 21, 2025

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden. [Read more]

Sector Healthcare
Founded 2009
Employees 8
Stock Exchange Nasdaq Stockholm
Ticker Symbol ACARIX
Full Company Profile

Financial Performance

In 2024, Acarix AB's revenue was 6.20 million, a decrease of -0.62% compared to the previous year's 6.24 million. Losses were -66.19 million, -14.97% less than in 2023.

Financial Statements

News

Acarix AB (publ) reports FY results

7 months ago - Seeking Alpha

Q3 2024 Acarix AB Earnings Call Transcript

Q3 2024 Acarix AB Earnings Call Transcript

10 months ago - GuruFocus